Characterization of soluble thrombomodulin levels in patients with stage 3–5 chronic kidney disease

Abstract

Soluble TM concentrations significantly increase in the CKD patients and are associated with the severity of the disease. Soluble TM may play critical roles in the development of CKD, as a biomarker of endothelial cells damage, anticoagulation and anti-inflammation.